Cargando…
Desferal regulates hCtr1 and transferrin receptor expression through Sp1 and exhibits synergistic cytotoxicity with platinum drugs in oxaliplatin-resistant human cervical cancer cells in vitro and in vivo
The development of resistance to platinum drugs in cancer cells severely reduces the efficacy of these drugs. Thus, the discovery of novel drugs or combined strategies to overcome drug resistance is imperative. In addition to our previous finding that combined D-penicillamine with platinum drugs exe...
Autores principales: | Chen, Szu-Jung, Kuo, Ching-Chuan, Pan, Hsin-Yi, Tsou, Tsui-Chun, Yeh, Szu-Ching, Chang, Jang-Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226510/ https://www.ncbi.nlm.nih.gov/pubmed/27384479 http://dx.doi.org/10.18632/oncotarget.10336 |
Ejemplares similares
-
Regulation of the high-affinity copper transporter (hCtr1) expression by cisplatin and heavy metals
por: Liang, Zheng Dong, et al.
Publicado: (2013) -
FGF13 enhances resistance to platinum drugs by regulating hCTR1 and ATP7A via a microtubule‐stabilizing effect
por: Yu, Hang, et al.
Publicado: (2021) -
Dynamical interplay between the human high-affinity copper transporter hCtr1 and its cognate metal ion
por: Walke, Gulshan, et al.
Publicado: (2022) -
A Deeper Insight in Metal Binding to the hCtr1 N-terminus Fragment: Affinity, Speciation and Binding Mode of Binuclear Cu(2+) and Mononuclear Ag(+) Complex Species
por: Magrì, Antonio, et al.
Publicado: (2022) -
Dual preventive benefits of iron elimination by desferal in asbestos‐induced mesothelial carcinogenesis
por: Jiang, Li, et al.
Publicado: (2016)